Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population-Reference-Cited by-同舟云学术

Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population

Published:2016-10 Issue:1 Volume:592 Page:15-22
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Bandaru Srinivas,Tarigopula Pramod,Akka Jyothy,Marri Vijaya Kumar,Kattamuri Ramesh Kumar,Nayarisseri Anuraj,Mangalarapu Madhavi,Vinukonda Swetha,Mundluru Hema Prasad,Sagurthi Someswar Rao^ORCID

Funder

Council of Scientific and Industrial Research

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference40 articles.

1. Analysis of ADRB2 (Arg16Gly) gene variant with susceptibility, pharmacogenetic response and disease severity in south Indian asthmatics;Bandaru;Inflammation,2015

2. Identification of high affinity bioactive salbutamol conformer directed against mutated (Thr164Ile) beta 2 adrenergic receptor;Bandaru;Curr. Top. Med. Chem.,2015

3. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003;Becker;Can. Med. Assoc. J.,2005

4. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version;Dean,2014

5. Therapeutic responses in asthma and COPD: bronchodilators;Donohue;CHEST Journal,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update;Expert Opinion on Drug Metabolism & Toxicology;2023-05-04

2. Molecular determinants of GPCR pharmacogenetics: Deconstructing the population variants in β2-adrenergic receptor;Membrane Proteins;2022

3. Pharmacogenomics of adrenergic receptors from bench to bedside: Potential clinical implications in critical care;Saudi Critical Care Journal;2022

4. Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC);Current Computer-Aided Drug Design;2021-07-15

5. A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma;Current Topics in Medicinal Chemistry;2021-05-26